Back to Research Home
SBCSBC Medical Group Holdings Incorporated
Health Care · Medical/Nursing Services · Small
$5.28−7.21%
As of 23 Oct 2026Mkt cap $435M
Stage 13
AVOID
Fundamentals
34.1/75
Technical
6.1/15
Independent
40.2/90
GCAE viewFundamental /75 is below the Stage 13 acceptable-business floor
Price
- 1M
- +11.2%
- 3M
- +65.5%
- 6M
- +57.6%
- 1Y
- +38.2%
Financials & valuation
Cached filing evidence · as of 2026-10-02
Valuation
- P/E
- 11.2xHist median 7.0x
- Forward P/E
- —No validated forward-estimate source
- Price / FCF
- 8.8x
- FCF yield
- 11.4%
Quality
- ROIC
- 35.9%
- Operating margin
- 36.5%
- FCF margin
- 13.4%
- Current ratio
- 3.8x
Growth
- Revenue growth
- −15.5%Latest FY YoY
- Revenue CAGR
- −5.3%
- EPS CAGR
- +9.1%
- FCF CAGR
- −25.7%
Capital
- Share-count trend
- +4.6%3Y annualised
- Net cash
- $112M-4.5x OCF
Annual trend
- CAGR 2023–2025
- −5.3%
- Latest · 2025
- $0B
- YoY
- −15.5%
GCAE Research
- Quality Research
- NOT FLAGGED
- Acceleration Radar
- NOT FLAGGED
- THE ONE
- NOT FLAGGED
- Final / Opportunity
- NOT FLAGGED
Key takeaway
Fundamental /75 is below the Stage 13 acceptable-business floor
Unresolved question
No reliable unresolved question is available from the current committed evidence.
Watch next
- Next earnings · 2026-11-13
More details & evidence
Production decision
- Stage 13
- AVOID
- Technical state
- extended
- Rotation
- tailwind
- Evidence
- fresh
Presentation freshness
- Stage 11 market
- 2026-10-23 · Massive
- Financial cache
- 2026-10-02
- Quality Research
- NOT FLAGGED
- THE ONE
- NOT FLAGGED
Authority
- Company page
- Presentation only
- Scores
- Frozen GCAE production outputs
- Research
- Research-only lanes; no score override
- Private portfolio
- Not loaded